2. Amyotrophic lateral sclerosis
508 clinical trials,   530 drugs   (DrugBank: 146 drugs),   170 drug target genes,   221 drug target pathways

Searched query = "Amyotrophic lateral sclerosis", "ALS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04090684
(ClinicalTrials.gov)
December 9, 201929/8/2019Ciprofloxacin/Celecoxib Combination in Patients With ALSOpen Label, Off Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALSALS (Amyotrophic Lateral Sclerosis)Drug: Fixed dose combination Ciprofloxacin/CelecoxibNeuroSense Therapeutics Ltd.NULLActive, not recruiting18 Years75 YearsAll11Phase 1United States
2NCT04165850
(ClinicalTrials.gov)
November 25, 201913/11/2019Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALSOpen Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALSAmyotrophic Lateral Sclerosis;ALSDrug: Fixed dose combination Ciprofloxacin/CelecoxibNeuroSense Therapeutics Ltd.NULLActive, not recruiting18 Years75 YearsAll16Phase 2Israel